About us

Pioneering medicinal and wellbeing cannabis research and manufacture

Medical Kiwi is a pioneering research and wellbeing company, creating and distributing medicinal and nutraceutical cannabis products, enabling those suffering from illness, seeking alternative pain medicine and improved wellbeing to have access to safe, effective, affordable, high quality products.
Hear Our Story
Register your interest

Opportunity

Significant changes in New Zealand’s legislation in 2018 have paved the way for the creation of a fully commercialised medical and nutraceutical cannabis industry. Medical Kiwi is in a unique position as one of a handful of New Zealand companies poised to create value and carve out a significant share of this emerging and exciting growth industry. The global opportunity that medicinal cannabis represents is estimated to reach USD $150 billion by 2025.

(Grand View Research, April 2018)

Medical Kiwi has a clear strategy for research, manufacturing, product, marketing, sales and distribution and an experienced Board of Directors with vast knowledge and expertise. This has put Medical Kiwi in the premier position to realise the global opportunities for a New Zealand produced and branded high quality, safe, effective and affordable medicinal and nutraceutical products to effect real changes in people’s lives and health outcomes.

Purpose

Medical Kiwi exists to enable those suffering from illness, seeking alternative pain management and improved wellbeing to have access to safe, effective, affordable high-quality medicinal and nutraceutical cannabis products.

Benefits

The positive effects of medicinal cannabis in improving the lives of people overseas are well documented and research is now emerging to support this. Internationally, scientists are conducting pre-clinical and clinical trials to test the efficacy of cannabis and its extracts to treat diseases that affect the immune system, inflammation, pain, seizures and psychological disorders.

Next: Our Process

Our process

The scope of our operations will comprise conducting research and development, cultivation, extraction, manufacturing, supply and distribution, and marketing of medicinal and nutraceutical cannabis products.

Research & Development

Advanced research and technology supporting the development of safe, high-quality medicinal cannabis products

Marketing

Correlate R&D with target market segments, to inform products, positioning and tactical marketing, including brand architecture

Cultivation

Breeding and growing safe, effective. cannabis strains of the highest quality

Manufacture

Creating fit-for-purpose, medicinal cannabis and nutraceutical products

Sales & Distribution

Via distribution, wholesale and online B2C

Next: Governance

Governance

Our Board of Directors will oversee Medical Kiwi’s operations, leveraging the sum of their professional and expert knowledge and proven track record of financial and management capability.

Next: Research and Development

Research and development

Research is key to the advancement of the medicinal cannabis industry and to Medical Kiwi. Ongoing research and development with swift adoption of relevant global technological advancements will mean we can be agile in our response to market needs and set an elevated benchmark as pioneers and leaders in the industry.

Our research schedule consists of:

  1. International collaboration regarding the effects of the bioactive components contained in cannabis.
  2. Research light effects on cannabinoid outcomes and conditions, in a replicable way.
  3. Develop, or contribute to, certification of standardisation of the beneficial bioactive properties of cannabis extracts.
  4. Establish protectable IP.
Next: Facility

Facility

Our state-of-the-art medicinal cannabis research, cultivation and processing facility will be based in Nelson, New Zealand.

We have secured an eight-hectare greenfield site in Brightwater which is strategically located for operational logistics and product distribution. Plans for a 8,000 – 10,000m2, two-story building were developed and submitted as part of our licence application. Sustainability and environmental responsibilities were central to the development of our building plans. Early engineering will maximise energy efficiency so that the entire building and growing system’s electricity can predominantly be powered by a one-megawatt solar system. When in full production, estimated to be early 2024, our facility is designed to produce 30,000 – 35,000 kgs of dried product per annum, valued today at between NZD $100 – $110 million.

Next: Investors

Information for investors

Medical Kiwi is an early-stage medicinal and nutraceuticals research and wellbeing company created to take advantage of the global opportunities that medicinal cannabis represents, forecast to be a USD $150 billion industry by 2025. (Global View Research, April 2018) Medical Kiwi has a clear strategy for research, manufacturing, product, marketing, sales and distribution and an experienced Board of Directors with vast knowledge and expertise. This has put Medical Kiwi in the premier position as one of a handful of New Zealand companies poised to create value and carve out a significant share of the emerging and exciting medicinal and wellbeing cannabis market in New Zealand.

Against the backdrop of a global health and wellness consumer mega-trend, and with sentiments and legislation towards alternative medicines, and medicinal cannabis in particular, rapidly evolving, the time is now to participate in the opportunity that Medical Kiwi represents.

Investment opportunity

Find out more about your chance to be a part of a global industry that will change the shape of the way the world delivers its health outcomes.

Next: The Offers

The offer

Medical Kiwi is seeking to raise investment capital to assist with local and global distribution and marketing, research and development, secondary processing, employment of critical staff, the build phase of our state-of-the-art facility. All shares on offer are full ordinary shares and their sale will be managed over three stages.

Infomation Memorandum

Medical Kiwi successfully completed seed funding in mid 2019. During this phase 100,000 shares were offered for sale to early investors, raising an initial NZD $1 million in investment capital. This has enabled Medical Kiwi to secure a greenfield site, complete design plans for a state-of-the-art facility and apply for licences.
Series A started in July 2019 with the intention to raise a further NZD $7.5 million. This will be achieved through the sale of 200,000 shares – 100,000 shares at a price of $30 per share through private wholesale investors and high net worth individuals, and 100,000 shares at a price of $45 per share through crowdfunding in September to December 2019.
In Series B, Medical Kiwi will undertake an initial public offering to raise $15 million through the issue of 300,000 – 900,000 shares. The raise will be facilitated by private funding or IPO.
Next: Reason to Invest

Reasons to invest

  1. We’re in a position to take advantage of rising demand and legislative changes that pave the way for a medicinal and nutraceuticals cannabis industry in New Zealand.
  2. We have a well-defined strategy and roadmap, with clear milestones to be achieved and will continue to be transparent about our KPI’s and milestones.
  3. Our business goals are aligned to environmental responsibility. We will look for opportunities and technology to ensure our practices are sustainable.
  4. Our R&D strategy will position us to develop proprietary IP and set an elevated benchmark as pioneers and leaders in the industry. This will ensure we deliver advanced, high-quality medicinal and nutraceutical cannabis products, with assurance from seed-to-sale.
  5. Our strong offshore partnerships are opening doors to international opportunities.
  6. Our Board of Directors have strong governance and management experience and expertise in science and medicine.
  7. We forecast we’ll start generating revenue in early 2021 with projected earnings showing a substantial return-on-investment and attractive dividend policy.


Next: Register

Find out more about your chance to be a part of a global industry that will change the shape of the way the world delivers its health outcomes.

Register your interest to receive more information about investing in the exciting future of Medical Kiwi.





Next: Newsroom
Next: Contact Us

Contact us

Fill in the form and we will reply as soon as possible,
or get in touch using the details below.

MEDICAL KIWI LIMITED
L1, 18 New St. Nelson 7010
PO Box 1671, Nelson 7040
New Zealand

Investor Portal

+61 4 21 497 138

invest@medicalkiwi.com






Scroll Up